Skip to content

Interoception-Based Yoga for Chronic Pain

Feasibility and Acceptability of Interoception-Based Yoga for Chronic Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06268197
Enrollment
26
Registered
2024-02-20
Start date
2024-02-16
Completion date
2025-03-24
Last updated
2025-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Brief summary

The purpose of this research is to examine the feasibility and acceptability of an interoception-based yoga program for chronic pain. Interoception involves your ability to feel sensations in your body (such as your heartbeat or muscle tension) as well as how you think about and interpret those sensations. Interoception may be an important component of chronic pain and the research team is studying whether yoga can change how you feel, think about, and interpret sensations in your body.

Interventions

BEHAVIORALYoga Intervention

The yoga intervention will consist of twice weekly, in-person, gentle Hatha yoga classes delivered by a certified yoga instructor. Each class will last 60-75 minutes and will include an introduction to the day's topic, an opening breathing/meditation practice, yoga postures, a closing breathing/meditation practice, and end with a savasana pose and intention setting for a home practice.

Sponsors

University of Illinois at Urbana-Champaign
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Self-reported chronic pain lasting ≥ 3 months (such as widespread musculoskeletal pain, fibromyalgia, migraine etc.) * In the past week, has pain interfered with your day-to-day activities? Yes * Self-reported ambulatory ability without an assistive device * Self-reported ability to get on and off the floor without assistance. * No ongoing mind-body practice (\<1x/week over the past 6 months). * Physical Activity Readiness Questionnaire Screen Pass or Physician Consent * English-speaking * Able and willing to provide consent * No plans to move or travel outside the area in the next 2 months

Exclusion criteria

* Ages \<18 or ≥ 65 at time of screening * Pain lasting \< 3 months * In the past week, has pain interfered with your day-to-day activities? No * Use of any assistive device (e.g. cane, walker, wheelchair). * Inability to get on and off the floor without assistance. * A consistent ongoing mind-body practice (mindfulness, yoga, meditation, tai chi, qigong), at least 1x/week over the past 6 months * Physical Activity Readiness Questionnaire Screen Fail or non-consent of physician * Non-English speaking * Non-consent * Plans to move or significant travel outside the area in the next 2 months * Known pregnancy * Recent surgery or acute bone, joint or nerve injury (within the past 6 months) * Severe or progressive neurological conditions such as Parkinson's disease, dementia, multiple sclerosis, or acquired brain injury * Separate pain-related diagnoses: cancer-related pain, complex regional pain syndrome, postural orthostatic tachycardia syndrome, functional neurological/ movement disorders * Active or planned worker's compensation or personal injury claim * Concurrent participation in another interventional study (e.g. physical activity, mind-body or drug trials)

Design outcomes

Primary

MeasureTime frameDescription
AcceptabilityPrimary endpoint: 6 weeksDefined as \>5/7 on acceptability questionnaire (1 = unacceptable, 7 = very acceptable)
FeasibilityPrimary endpoint: 6 weeksDefined as achieving the target recruitment sample (N=25) in a 9-month period, 80% retention (N=20), 70% attendance rate, 70% home practice adherence and no serious adverse events.

Secondary

MeasureTime frameDescription
Interoceptive SensibilityPrimary endpoint: 6 weeksMultidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-2). Will take the mean of 5 MAIA-2 Subscales: attention regulation, emotional awareness, self-regulation, body listening, and trusting as the primary measure of preliminary efficacy. Planned post-hoc analyses will evaluate differential changes in all 8 subscales.
PROMIS Pain InterferencePrimary endpoint: 6 weeksShort Form 8a

Other

MeasureTime frameDescription
PROMIS Pain IntensityPrimary endpoint: 6 weeksShort Form 3a, planned covariate for pain interference.
Quality of LifePrimary endpoint: 6 weeks36-Item Short Form Health Survey (SF-36)
Spiritual WellbeingPrimary endpoint: 6 weeksFunctional Assessment of Chronic Illness Therapy - Spiritual Wellbeing Scale (FACIT-Sp12)
Pain ImpactPrimary endpoint: 6 weeksASCQ Pain Impact Short Form
MindfulnessPrimary endpoint: 6 weeksFive Facet Mindfulness Questionnaire (FFMQ), planned covariate for interoceptive sensibility
Interoceptive AccuracyPrimary endpoint: 6 weeksHeartbeat Tracking Task

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026